NCT00346918View on ClinicalTrials.gov

Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

June 30, 2010

Conditions
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions
DRUG

Sirolimus

Standard plus Sirolimus

OTHER

Standard

Standard

Trial Locations (1)

8091

University Hospital, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT00346918 - Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Biotech Hunter | Biotech Hunter